Detalles de la búsqueda
1.
Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study.
J Infect Dis
; 212(1): 72-80, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25538277
2.
Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture-derived H5N1 (aH5n1c) influenza vaccine in adults and older adults.
Hum Vaccin Immunother
; 19(1): 2193119, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057755
3.
Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50-64 Years of Age.
Vaccines (Basel)
; 11(10)2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896932
4.
Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects.
Vaccines (Basel)
; 10(4)2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35455245
5.
Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.
Pediatrics
; 150(5)2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214072
6.
A Prospective Cohort Study on Pregnancy Outcomes of Persons Immunized with a Seasonal Quadrivalent Inactivated Influenza Vaccine during Pregnancy.
Vaccines (Basel)
; 10(10)2022 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298442
7.
Outcomes in Pregnant Persons Immunized with a Cell-Based Quadrivalent Inactivated Influenza Vaccine: A Prospective Observational Cohort Study.
Vaccines (Basel)
; 10(10)2022 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298465
8.
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine
; 39(47): 6930-6935, 2021 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711436
9.
Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults.
Vaccines (Basel)
; 9(12)2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34960214
10.
Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects.
Pediatr Infect Dis J
; 38(7): 757-764, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31194712
11.
Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly.
Open Forum Infect Dis
; 6(4): ofz107, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968056
12.
A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults.
Sci Transl Med
; 6(234): 234ra55, 2014 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24786323
13.
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.
Hum Vaccin Immunother
; 10(2): 280-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24220326
14.
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
Vaccine
; 32(8): 965-72, 2014 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24397906
15.
Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age.
Pediatr Infect Dis J
; 31(4): e59-65, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22418661
16.
Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
Vaccine
; 28(1): 256-60, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19799842
17.
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.
Clin J Am Soc Nephrol
; 4(2): 428-34, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19118117
Resultados
1 -
17
de 17
1
Próxima >
>>